22.21MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-06-18The current institutional shareholding score of Marker Therapeutics Inc is 3.00, ranking 193 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 26.04%, representing a quarter-over-quarter increase of 17.09%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.05% of shares outstanding, with 0.13% decrease in holdings.
Institutional Shareholding
Shareholder Activity
New Enterprise Associates (NEA)
Blue Owl Capital Holdings LP
Aisling Capital Management LP
Geode Capital Management, L.L.C.
Two Sigma Investments, LP